Context Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CNTX Key Statistics
Stock Snapshot
With a market cap of 241.64M, Context Therapeutics(CNTX) trades at $2.66. The stock has a price-to-earnings ratio of -6.82.
On 2026-03-31, Context Therapeutics(CNTX) stock moved within a range of $2.45 to $2.67. With shares now at $2.66, the stock is trading +8.6% above its intraday low and -0.4% below the session's peak.
Trading volume for Context Therapeutics(CNTX) stock has reached 390.31K, versus its average volume of 688.89K.
The stock's 52-week range extends from a low of $0.49 to a high of $3.62.
The stock's 52-week range extends from a low of $0.49 to a high of $3.62.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.